Autres langues Renalytix Plc Nasdaq

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,7001 ^USD	-7,76%		+11,34%	+79,51%

18/04	Le directeur général de Renalytix devient président	AN
18/04	Renalytix plc annonce des changements exécutifs à compter du 30 avril 2024	CI

Pentwater Capital Management LP - Form 8.3 - Renalytix PLC	26/04
Renalytix chief business officer to become president	18/04
Renalytix Names Chief Business Officer as President	18/04
Renalytix plc Announces Executive Changes, Effective from April 30, 2024	18/04
Renalytix Issues New Shares for Convertible Bonds Repayment	10/04
FTSE 100 Index Closes Up 0.4% Lifted by Miners	08/04
Renalytix announces financing of up to USD4 million	08/04
Renalytix to Raise Up to $4 Million via Share Offering	08/04
Renalytix plc Announces Change of Registered Office Address	04/04
Renalytix : Notification letter April 2024	03/04
Form 8.5 (EPT/RI) - Renalytix plc	03/04
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	15/03
Horizonte subsidiary hit with debt injunction	14/03
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	14/03
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	14/03
Renalytix plc's KidneyIntelX Included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease	14/03
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	13/03
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	13/03
ADRs End Higher, ATRenew Inc. Climbs 26.9%	12/03
Renalytix Raises $12 Million via Equity Placing to Extend Cash Runway	12/03

Aucun résultat pour cette recherche